✦ LIBER ✦

Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade

✍ Scribed by Fernando A. Cura; Samir R. Kapadia; Philippe L. L’Allier; Jakob P. Schneider; Mark S. Kreindel; Mitchell J. Silver; Jay S. Yadav; Conrad C. Simpfendorfer; Russel R. Raymond; E.Murat Tuzcu; Irving Franco; Patrick L. Whitlow; Eric J. Topol; Stephen G. Ellis

Book ID: 113974175
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 86 KB
Volume: 86
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(00)01081-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Coronary perforation during percutaneous

Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management

✍ Eric J. Dippel; Dean J. Kereiakes; Daniel A. Tramuta; Thomas M. Broderick; Thoma 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 2 views

Clinical correlates and course of thromb

Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade

✍ Dean J. Kereiakes; Scott D. Berkowitz; A.Michael Lincoff; James E. Tcheng; Kathy 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Incidence and Predictors of Major Vascul

Incidence and Predictors of Major Vascular Complications after Percutaneous Coronary Intervention in the Glycoprotein IIb/IIIa Platelet Inhibitor Era

✍ RICHARD KONSTANCE; JAMES E. TCHENG; MARILYN B. WIGHTMAN; LARRY P. KELLY; ANNETTE 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Direct Thrombin Inhibitors for Percutane

Direct Thrombin Inhibitors for Percutaneous Coronary Intervention in the Current Era of Platelet Glycoprotein IIb/IIIa Inhibition

✍ JOEL P. REGINELLI; DEREK CHEW 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Risk factors for the development of retr

Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices

✍ H.M. Omar Farouque; Jennifer A. Tremmel; Farshad Raissi Shabari; Meenakshi Aggar 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Vascular closure devices and the risk of

Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors

✍ Frederic S Resnic; Gavin J Blake; Lucila Ohno-Machado; Andrew P Selwyn; Jeffrey 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 108 KB